Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate
Pricing Report NDC 43975-334-10

Latest NADAC: $0.62500 per EA · Effective Sep 21, 2022 · Est. package price $62.50 (100 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate (NDC 43975-334-10) is $0.62500 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 21, 2022.

As a provided by Amerigen Pharmaceuticals Inc., this medication is distributed in a 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.62500
Per EA

Effective Date
Sep 21, 2022
Billable Units
100 EA
Estimated Package Price
$62.50
Data Status
As of Sep 28, 2022
C/I - Chain or Independent Pharmacy
Package NDC
Description
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jan 2019, the NADAC wholesale price for (NDC ) has moved within a range of $0.54549 to $1.96317 per EA. Over this 3 years and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.5455 - $1.9632
Market Volatility
259.89% Variance
Latest Trend
7.84%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 21, 2022 $0.62500 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 17, 2022 $0.67819 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 20, 2022 $0.60990 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 22, 2022 $0.59509 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 18, 2022 $0.60768 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 20, 2022 $0.57765 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 23, 2022 $0.58746 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 23, 2022 $0.55346 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 19, 2022 $0.60438 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 22, 2021 $0.54549 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 17, 2021 $0.60990 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 20, 2021 $0.61152 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026